Found 6 articles for: "Bullous Pemphigoid"
Treatment of Bullous Pemphigoid With Dupilumab: A Case Series of 30 Patients
June 2024 | Volume 23 | Issue 6 | Editorials | e144 | Copyright © June 2024
Bullous pemphigoid is often difficult to treat with the limited therapies available. Here, we describe clinical outcomes among 30 adults with bullous pemphigoid patients treated with dupilumab. W...
Read MoreThe Koebner Phenomenon in Bullous Pemphigoid
April 2024 | Volume 23 | Issue 4 | Case Reports | e100 | Copyright © April 2024
Erythrodermic Bullous Pemphigoid in Skin of Color Treated With Dupilumab
July 2023 | Volume 22 | Issue 7 | Case Reports | 685 | Copyright © July 2023
Bullous pemphigoid (BP) is an autoimmune blistering disease that typically presents with pruritic, tense bullae in elderly patients.1 Several recognized presentations deviate from the ...
Read MoreBullous Pemphigoid and Scabies: Is There an Association?
September 2022 | Volume 21 | Issue 9 | Original Article | 1009 | Copyright © September 2022
Background: Bullous Pemphigoid (BP) is an autoimmune subepithelial bullous disease. Several reports suggested an association between BP and scabies.
Objective: ...
Read MoreRituximab-Induced Alopecia Universalis in a Patient With Bullous Pemphigoid
August 2022 | Volume 21 | Issue 8 | Case Reports | 894 | Copyright © August 2022
Alopecia areata is a CD8+ T-lymphocyte driven autoimmune disorder leading to reversible hair loss. While most commonly presenting as isolated well-demarcated non-cicatricial alopecic patches on the sc...
Read MoreThe Use of Mycophenolate Mofetil in the Treatment of Bullous Pemphigoid
February 2022 | Volume 21 | Issue 2 | Original Article | 151 | Copyright © February 2022
Background: The first-line treatment for patients with bullous pemphigoid (BP), the most common autoimmune blistering disease, is systemic glucocorticoids, which are associated with n...
Read More